Bicycle Therapeutics Closes $6M Round
Bicycle Therapeutics has closed on 3.75 million ($6 million) in new funding. Current investors Atlas Venture, Novartis Venture Fund, SR One and SV Life Sciences were joined by new investor Astellas Venture Management, the venture capital arm of Astellas Pharma. Bicycle Therapeutics is a biotechnology company based in Cambridge, U.K.
10 December 2012•2 mins read
